Construction and expression of a novel bioactive IFN-α2b/CM4 fusion protein in Escherichia coli

Microbiological Research

Volumn 165, Issue 2, 2010, Pages 116-121

  Li, Nan Nan ^a   Liu, Ping ^a   Chen, Su Juan ^a   Lin, Qing Ping ^a   Zhou, Liang Fan ^a   Zhang, Shuang Quan ^a  

^a NANJING NORMAL UNIVERSITY   (China)

Author keywords

Antibacterial peptide CM4; Escherichia coli; Fusion protein; Human interferon alpha2b

Indexed keywords

ANTI-FUNGAL ACTIVITY; ANTI-TUMOR ACTIVITIES; ANTIBACTERIAL PEPTIDE CM4; ANTIBACTERIAL PEPTIDES; CYTOKINES; FUSION PROTEIN; FUSION PROTEINS; PROTEIN EXPRESSION SYSTEMS; PURIFICATION PROTOCOL; REFOLDING; TUMOR CELLS;

ANTIBIOTICS; DIALYSIS; ESCHERICHIA COLI; GLYCOPROTEINS; PHOSPHATASES;

PEPTIDES;

ALPHA2B INTERFERON; ANTIINFECTIVE AGENT; ANTIMICROBIAL CATIONIC PEPTIDE; ANTINEOPLASTIC AGENT; CM4 PEPTIDE, BOMBYX MORI; HYBRID PROTEIN;

ANTIMICROBIAL ACTIVITY; BIOACTIVITY; CANCER; FECAL COLIFORM; GENE EXPRESSION; HORMONE; INHIBITION; PEPTIDE; PLEIOTROPY; PROTEIN; TUMOR;

ANIMAL; ARTICLE; BACTERIUM; CELL INCLUSION; DRUG EFFECT; EPITHELIUM CELL; ESCHERICHIA COLI; FUNGUS; GENETICS; HUMAN; ISOLATION AND PURIFICATION; PROTEIN FOLDING; TUMOR CELL LINE;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIMICROBIAL CATIONIC PEPTIDES; ANTINEOPLASTIC AGENTS; BACTERIA; CELL LINE, TUMOR; EPITHELIAL CELLS; ESCHERICHIA COLI; FUNGI; HUMANS; INCLUSION BODIES; INTERFERON ALFA-2B; PROTEIN FOLDING; RECOMBINANT FUSION PROTEINS;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; FUNGI;

EID: 74149094507     PISSN: 09445013     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micres.2009.01.002     Document Type: Article

References (17)

1. Boman H.G. Antibacterial peptides: basic facts and emerging concepts. J Intern Med 254 (2003) 197-215
2. Cao P., Zhang S.Q., Zhang J., and Wang M. Construction and characterization of a bi-functional EGFP/sBAFF fusion protein. Biochimie 88 (2006) 629-635
3. Kuper H., Adami H.O., and Trichopoulos D. Infections as a major preventable cause of human cancer. J Intern Med 248 (2000) 171-183
4. Li B.C., Zhang S.Q., Dan W.B., Chen Y.Q., and Cao P. Expression in Escherichia coli and purification of bioactive antibacterial peptide ABP-CM4 from the Chinese silk worm, Bombyx mori. Biotechnol Lett 29 (2007) 1031-1036
5. Liu F., Chen Z., Jiang W.G., Yang C.Z., Xiong D.S., and Zhu Z.P. Improvement in soluble expression levels of a diabody by exchanging expression vectors. Protein Expres Purif 62 (2008) 15-20
6. Lu J.X., Peng P., Meng Z.F., Jin L.Q., Lu Y.S., and Guan M.X. Rational design of an EGF-IL18 fusion protein: implication for developing tumor therapeutics. Biochem Biophys Res Commun 334 (2005) 157-161
7. Mogensen K.E., Lewerenz M., Reboul J., Lutfalla G., and Uze G. Type I IFN receptor: structure, function, and evolution of a family business. J Interferon Cytokine Res 19 (1999) 1069-1098
8. Nyman T.N., Tolo H., Parkkinen J., and Kalkkinen N. Identification of nine interferon-α subtypes produced by sendai virus-induced human peripheral blood leukocytes. J Biochem 329 (1998) 295-302
9. Park Y., Lee D.G., Jang S.H., Woo E.R., Jeong H.G., Choi C.H., et al. A Leu-Lys-rich antimicrobial peptide: activity and mechanism. Biochim Biophys Acta 1645 (2003) 172-182
10. Pfeffer L.M., Dinarello C.A., Herberman R.B., Williams B.R., Borden E.C., Bordens R., et al. Biological properties of recombinant alpha-interferons: 40th anniversary of the discovery of interferons. Cancer Res 58 (1998) 2489-2499
11. Srivastava P., Bhattacharaya P., Pandey G., and Mukherjee K.J. Overexpression and purification of recombinant human interferon alpha 2b in Escherichia coli. Protein Expres Purif 41 (2005) 313-322
12. Stark J.J., Dillman R.O., Schulof R., Wiemann M.C., Barth N.M., Honeycutt P.J., et al. Interferon-alpha and chemohormonal therapy for patients with advanced melanoma: Wnal results of a phase I-II study of the cancer biotherapy research group and the mid-Atlantic oncology program. Cancer 82 (1998) 1677-1681
13. Tamura T., Ueda S., Yoshida M., Matsuzaki M., Mohri H., and Okubo T. Interferon-γ induces ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell. Biochem Biophys Res Commun 229 (1996) 21-26
14. Vilcek J. Fifty years of interferon research: aiming at a moving target. Immunity 25 (2006) 343-348
15. Vyas S.P., Rawat M., Rawat A., Mahor S., and Gupta P.N. Pegylated protein encapsulated multivesicular liposomes: a novel approach for sustained release of interferon alpha. Drug Dev Ind Pharm 32 (2006) 699-707
16. Walsh T.J., Finberg R.W., Arndt C., Hiemenz J., Schwartz C., Bodensteiner D., et al. Liposomal amphotericin B for empirical therapy in patients with persistent and neutropenia. N Engl J Med 346 (2002) 225-234
17. Zhang J., Zhang S.Q., Wu X., Chen Y.Q., and Diao Z.Y. Expression and characterization of antimicrobial peptide ABP-CM4 in methylotrophic yeast Pichia pastoris. Process Biochem 41 (2006) 251-256